NZQA Expiring unit standard
25264 version 2
Page 1 of 6
Title
Demonstrate knowledge of human musculoskeletal, integumentary
systems, eye and ear and medicines used in their treatment
Level
5
Purpose
Credits
9
This unit standard is intended for pharmacy technicians or
people working towards a pharmacy technician qualification.
People credited with this unit standard are able to demonstrate
knowledge of: the structure and function of muscles and the
musculoskeletal system; the structure and function of the
integumentary system; the structure and function of the eye
and ear; musculoskeletal disorders and the medicines used in
their treatment; integumentary disorders and medicines used in
their treatment; and common disorders of the eye and ear and
medicines used in their treatment.
Classification
Pharmacy > Pharmacy Services
Available grade
Achieved
Entry information
Critical health and
safety prerequisites
Open.
This unit standard is
Pharmacy technicians must act
within the legislative limits of their role as specified by
expiring
the Medicines Regulations 1984 and must always act under the supervision of a
Explanatory notes
1
pharmacist and under the direct personal supervision of a pharmacist when
dispensing or compounding.
2
Legislation, codes, and standards relevant to this unit standard include:
Consumer Guarantees Act 1993;
Fair Trading Act 1986;
Hazardous Substances and New Organisms Act 1996;
Health and Disability Commissioner (Code of Health and Disability Services Consumers’
Rights) Regulations 1996;
Code of Health and Disability Services Consumers’ Rights, available from the Health and
Disability Commissioner’s office;
Health Information Privacy Code 1994, available from the Privacy Commissioner’s office;
Health (Retention of Health Information) Regulations 1996;
Health (Needles and Syringes) Regulations 1998;
Health and Safety in Employment Act 1992;
Pharmacy Industry Training Organisation
SSB Code 102150
 New Zealand Qualifications Authority 2016
NZQA Expiring unit standard
25264 version 2
Page 2 of 6
Health and Safety in Employment Regulations 1995;
Medicines Act 1981;
Medicines Regulations 1984;
Misuse of Drugs Act 1975;
Misuse of Drugs Regulations 1977;
Privacy Act 1993, and any subsequent amendments;
New Zealand Code of Good Manufacturing Practice for Manufacture and Distribution of
Therapeutic Goods, Part 3 Compounding and Dispensing (1993), available from
Medsafe;
The New Zealand Pharmaceutical Schedule, available from http://www.pharmac.govt.nz;
Pharmacy Council of New Zealand Code of Ethics 2004, available at
http://www.pharmacycouncil.org.nz.
3
Access to appropriate reference resources in accordance with Medsafe audit
requirements is required for completion of assessment against this unit standard.
Evidence presented by the candidate must be in accordance with reference resources.
4
This unit standard is designed to cover knowledge sufficient to provide, under direct
personal supervision of a pharmacist, client counselling when dispensed medicine is
handed out.
The Pharmacy Council advises the public that before leaving the pharmacy they will
receive counselling that confirms and explains:
who the medicine is for
what the medicine is for
the directions for proper use and what special precautions to take
foods or medicines to avoid
common side effects or interactions, what to expect and how to treat, if needed
how soon to expect the medicine to work
what to do if you miss a dose
how to store your medicine and dispose of unused medicines safely
if there are repeats or a balance owing and how and when to collect them.
This unit standard is
expiring
Musculoskeletal disorders include but are not limited to – arthritis, cramp, fractures,
This information is available on the Pharmacy Council website:
www.pharmacycouncil.org.nz.
5
gout, inflammation, neuromuscular disorders, osteoporosis, overuse syndrome,
sprains, strains.
Integumentary disorders include but are not limited to – acne, allergy, bites and/or stings,
callus and/or corns, dandruff, dermatitis, dry skin, infection, psoriasis, warts.
Eye disorders include but are not limited to – allergy, conjunctivitis (allergic, bacterial,
viral), dry eye, glaucoma, infection, styes, minor eye irritations, macular
degeneration.
Ear disorders include but are not limited to – infection, balance disorder.
Outcomes and evidence requirements
Outcome 1
Demonstrate knowledge of the structure and function of muscles and the musculoskeletal
system.
Pharmacy Industry Training Organisation
SSB Code 102150
 New Zealand Qualifications Authority 2016
NZQA Expiring unit standard
25264 version 2
Page 3 of 6
Evidence requirements
1.1
The location and structure of the bones and articulations of the skeleton are
identified and explained in terms of their function.
1.2
Bone growth, maintenance, and repair are explained in terms of the roles of
bone cells, hormones, vitamins, and minerals.
Range
1.3
includes but is not limited to – bone cells, oestrogen, calcium,
vitamin D.
Muscle types and associated structures are identified and explained in terms of
their location, structure, and function.
Range
includes but is not limited to – skeletal muscle, smooth muscle,
cardiac muscle, fascia, tendons, ligaments.
Outcome 2
Demonstrate knowledge of the structure and function of the integumentary system.
Evidence requirements
2.1
The location and structure of parts of the integumentary system and associated
structures are identified and explained in terms of their function.
Range
includes but is not limited to – epidermis, dermis, hypodermis,
adipose tissue, blood vessels, hair follicles, nerve endings,
sebaceous glands, sweat glands, nails.
This unit standard is
Outcome 3
expiring
Demonstrate knowledge of the structure and function of the eye and ear.
2.2
The maintenance and repair of the epidermis is explained in terms of the
cellular processes.
Evidence requirements
3.1
The location and structure of the parts of the eye are identified and explained in
terms of their function.
3.2
The location and structure of the parts of the inner, outer, and middle ear are
identified and explained in terms of their function.
3.3
The maintenance of balance is explained in terms of the function of the ear.
Range
includes but is not limited to – static equilibrium, dynamic
equilibrium.
Pharmacy Industry Training Organisation
SSB Code 102150
 New Zealand Qualifications Authority 2016
NZQA Expiring unit standard
25264 version 2
Page 4 of 6
Outcome 4
Demonstrate knowledge of musculoskeletal disorders and the medicines used in their
treatment.
Range
medicines include but are not limited to – analgesics, anticholinesterases,
antigout drugs, bisphosphonates, botulinum toxin, calciferol, calcium,
corticosteroids, immunosuppressants, non-steroidal anti-inflammatory drugs,
quinine, rubefacients, skeletal muscle relaxants.
Evidence requirements
4.1
Musculoskeletal disorders and their signs and symptoms are identified and
explained in terms of the effects on body functions.
4.2
Medicines are identified according to their use for treatment of musculoskeletal
disorders.
4.3
Actions and limitations of the medicines are identified and explained in terms of
the effects on body functions.
Range
4.4
may include but is not limited to – cautions, contra-indications,
clinically significant adverse effects, drug interactions.
Type of advice required by the Pharmacy Council for pharmacy clients is
identified.
Range
evidence is required for a minimum of one treatment for a
musculoskeletal disorder.
Outcome 5
This unit standard is
medicines include but are not limited to – anti-acne drugs; anti-dandruff;
antipruritics; corticosteroids;
disinfectants and cleansing preparations;
expiring
emollients; local anaesthetics; preparations for psoriasis and eczema;
Demonstrate knowledge of integumentary disorders and medicines used in their treatment.
Range
preparations for warts, corns, and calluses; sunscreens.
Evidence requirements
5.1
Integumentary disorders and their signs and symptoms are identified and
explained in terms of the effects on body functions.
5.2
Medicines are identified according to their use for treatment of integumentary
disorders.
5.3
Actions and limitations of the medicines are identified and explained in terms of
their effect on body functions.
Range
may include but is not limited to – cautions, contra-indications,
clinically significant adverse effects, drug interactions.
Pharmacy Industry Training Organisation
SSB Code 102150
 New Zealand Qualifications Authority 2016
NZQA Expiring unit standard
5.4
25264 version 2
Page 5 of 6
Type of advice required by the Pharmacy Council for pharmacy clients is
identified.
Range
evidence is required for a minimum of one treatment for an
integumentary disorder.
Outcome 6
Demonstrate knowledge of common disorders of the eye and ear and medicines used in
their treatment.
Range
medicines may include but are not limited to – anti-inflammatories,
antihistamines, corticosteroids, cycloplegics, glaucoma drugs,
immunomodulators, mydriatics, miotics, ocular lubricants, ocular decongestants.
Evidence requirements
6.1
Disorders of the eye and ear and their signs and symptoms are identified and
explained in terms of the effects on body functions.
6.2
Medicines are identified according to their use for treatment of disorders of the
eye and ear.
6.3
Actions and limitations of the medicines are identified and explained in terms of
their effect on body functions.
may include but is not limited to – cautions, contra-indications,
clinically significant adverse effects, drug interactions.
Range
6.4
Type of advice required by the Pharmacy Council for pharmacy clients is
identified.
This
unit
is for an eye
evidence
is requiredstandard
for a minimum of one treatment
disorder and one treatment for an ear disorder.
expiring
Range
This unit standard is expiring. Assessment against the standard must take place by
the last date for assessment set out below.
Status information and last date for assessment for superseded versions
Process
Version Date
Last Date for Assessment
Registration
1
21 November 2008
31 December 2017
Review
2
16 April 2015
31 December 2017
Consent and Moderation Requirements (CMR) reference
0128
This CMR can be accessed at http://www.nzqa.govt.nz/framework/search/index.do.
Pharmacy Industry Training Organisation
SSB Code 102150
 New Zealand Qualifications Authority 2016
NZQA Expiring unit standard
25264 version 2
Page 6 of 6
Please note
Providers must be granted consent to assess against standards (accredited) by NZQA,
before they can report credits from assessment against unit standards or deliver courses
of study leading to that assessment.
Industry Training Organisations must be granted consent to assess against standards by
NZQA before they can register credits from assessment against unit standards.
Providers and Industry Training Organisations, which have been granted consent and
which are assessing against unit standards must engage with the moderation system that
applies to those standards.
Requirements for consent to assess and an outline of the moderation system that applies
to this standard are outlined in the Consent and Moderation Requirements (CMR). The
CMR also includes useful information about special requirements for organisations wishing
to develop education and training programmes, such as minimum qualifications for tutors
and assessors, and special resource requirements.
This unit standard is
expiring
Pharmacy Industry Training Organisation
SSB Code 102150
 New Zealand Qualifications Authority 2016